FULC Competitors & Alternatives
Compare Fulcrum Therapeutics Inc with similar stocks in the same industry
Biotechnology
FULC
Main Stock$7.44
Tradestie Score
57
Market Cap
$504.67M
Revenue Growth
-1.0%
Analyst Upside
+155.4%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$4.12
|
$552.46M | - | 52 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$15.62
|
$540.97M | - | 56 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$11.51
|
$533.99M | - | 63 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.90
|
$529.35M | 7.3 | 57 | Compare |
|
OCGN
Ocugen, Inc. Common Stock
|
$1.66
|
$524.67M | - | 52 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.66
|
$512.39M | - | 57 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$30.56
|
$505.12M | 1.6 | 64 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$130.67
|
$492.21M | - | 57 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.86
|
$474.20M | 28.7 | 53 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$4.86
|
$468.01M | - | 53 | Compare |
More FULC Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry